A detailed overview on pharmaceutical dosage forms in treatment of acne
Keywords:
acne, treatment, dosage forms, topical treatment, systemic therapyAbstract
Acne vulgaris is a skin condition characterized by an obstruction or inflammation of the oil glands, present on skin's surface, which are collectively termed as pilosebaceous units. The skin on face, back, and upper chest have a greater number of sebaceous follicles. Topical, systemic, or combination therapy can be used to treat acne, while mild and moderate acne are generally treated with topical therapy. Topical acne therapy has direct access to the target site (skin) prior to reaching the blood stream, thereby reducing the systemic adverse effects of delivery of drug via parenteral or oral routes. Oral antibiotics, on the other hand, are a crucial treatment for acne which have not improved with topical treatment and for inflammatory lesions, such as pustules, nodules, and papules. Due to their capability to improve dermal therapeutics by boosting therapeutic efficacy and lowering adverse effects, nanodelivery technologies, developed to address skin delivery difficulties, have been extensively investigated. The goal of this study is to go through the many types of pharmacological dosage forms that are available for the treatment of acne.
Downloads
References
Abd-Allah H, Abdel-Aziz RTA, Nasr M. Chitosan nanoparticles making their way to clinical practice: A feasibility study on their topical use for acne treatment. Int J Biol Macromol. 2020;156:262-270. doi:10.1016/j.ijbiomac.2020.04.040
Amer SS, Nasr M, Mamdouh W, Sammour O. Insights on the use of nanocarriers for acne alleviation. Current Drug Delivery. 2019 Jan 1;16(1):18-25.
Armstrong AW, Hekmatjah J, Kircik LH. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists. Journal of Drugs in Dermatology: JDD. 2020 Nov 1;19(11):s6-13.
Baldwin H. Oral Antibiotic Treatment Options for Acne Vulgaris. J Clin Aesthet Dermatol. 2020;13(9):26-32.
Batara, R., Ardani, I. G. A. I., Wardani, I. A. K., Windiani, I. G. A. T., Adnyana, I. G. A. N. S., & Setiawati, Y. (2022). Psychogenic dysphagia in children, and the success of family-based treatment: Case report. International Journal of Health & Medical Sciences, 5(1), 163-168. https://doi.org/10.21744/ijhms.v5n1.1894
Benner N, Sammons D. Overview of the treatment of acne vulgaris. Osteopathic Family Physician. 2013 Sep 1;5(5):185-90.
Bhalerao, S.S.; Raje, H.A. Preparation, optimization, characterization, and stability studies of salicylic acid liposomes. Drug Dev. Ind. Pharm., 2003, 29(4), 451-467.
Borges, V.R.; Simon, A.; Sena, A.R.; Cabral, L.M.; de Sousa, V.P. Nanoemulsion containing dapsone for topical administration: A study of in vitro release and epidermal permeation. Int. J. Nanomed., 2013, 8, 535-544.
Chakraborty N, Narayanan V, Gautam HK. Nano-Therapeutics to Treat Acne Vulgaris. Indian Journal of Microbiology. 2022 Jan 29:1-8.
Chien AL, Qi J, Rainer B, Sachs DL, Helfrich YR. Treatment of acne in pregnancy. The Journal of the American Board of Family Medicine. 2016 Mar 1;29(2):254-62.
Date AA, Naik B, Nagarsenker MS. Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol. 2006;19(1):2-16. doi:10.1159/000089138
De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatologic surgery. 2004 Apr;30(4p2):656-61.
Del Rosso JQ. Topical and oral antibiotics for acne vulgaris. , 35, 2. 2016 Jun 1;35(2):57-61.
Domínguez-delgado, C.L.; Rodríguez-cruz, I.M.; Escobar-chávez, J.J.; Calderón-lojero, I.O.; Quintanar-guerrero, D.; Ganem, A. Preparation and characterization of triclosan nanoparticles intended to be used for the treatment of acne. Eur. J. Pharm. Biopharm., 2011, 79(1), 102-107.
Dréno B, Layton A, Zouboulis CC, Lopez‐Estebaranz JL, Zalewska‐Janowska A, Bagatin E, Zampeli VA, Yutskovskaya Y, Harper JC. Adult female acne: a new paradigm. Journal of the European Academy of Dermatology and Venereology. 2013 Sep;27(9):1063-70.
Farrah G, Tan E. The use of oral antibiotics in treating acne vulgaris: a new approach. Dermatologic Therapy. 2016 Sep;29(5):377-84.
Feldman S, Careccia RE, Barham KL, Hancox JG. Diagnosis and treatment of acne. American Family Physician. 2004 May 1;69(9):2123-30.
Feneran AN, Kaufman WS, Dabade TS, Feldman SR. Retinoid plus antimicrobial combination treatments for acne. Clinical, Cosmetic and Investigational Dermatology. 2011;4:79.
Fluhr, J.W.; Barsom, O.; Gehring, W.; Gloor, M. Antibacterial efficacy of benzoyl peroxide in phospholipid liposomes. A vehiclecontrolled, comparative study in patients with papulopustular acne. Dermatology, 1999, 198(3), 273-277.
Fox L, Csongradi C, Aucamp M, Du Plessis J, Gerber M. Treatment modalities for acne. Molecules. 2016 Aug;21(8):1063.
Ghabdian Y, Taheri A, Jahanian-Najafabadi A. Development of novel topical formulation from fullerene with antibacterial activity against Propionibacterium acnes. Fullerenes, Nanotubes and Carbon Nanostructures. 2021 Feb 1;29(2):163-73.
Graber EM. Treating acne with the tetracycline class of antibiotics: A review. Dermatological Reviews. 2021 Dec;2(6):321-30.
Gupta S, Wairkar S, Bhatt LK. Isotretinoin and α-tocopherol acetate-loaded solid lipid nanoparticle topical gel for the treatment of acne. Journal of microencapsulation. 2020 Nov 16;37(8):557-65.
Harper JC, Roberts WE, Zeichner JA, Guenin E, Bhatt V, Pillai R. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups. J Dermatolog Treat. 2020;31(2):160-167. doi:10.1080/09546634.2019.1587884
Hebert A, Thiboutot D, Stein Gold L, et al. Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials. JAMA Dermatol. 2020;156(6):621-630. doi:10.1001/jamadermatol.2020.0465
Honzak, L.; Sentjurc, M. Development of liposome encapsulated clindamycin for treatment of acne vulgaris. Pflugers Arch., 2000, 440(Suppl 1), R044-R045.
Hsieh MF, Chen CH. Delivery of pharmaceutical agents to treat acne vulgaris: current status and perspectives. J Med Biol Eng. 2011;32(4):215-24.
Hsu P, Litman GI, Brodell RT. Overview of the treatment of acne vulgaris with topical retinoids. Postgraduate Medicine. 2011 May 1;123(3):153-61.
In Ryu S, Suh DH, Lee SJ, Kim KE, Jeong JY, Ryu HJ. Efficacy and safety of intense pulsed light using a dual-band filter for the treatment of facial acne vulgaris. Lasers in Medical Science. 2022 Feb;37(1):531-6.
InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Acne: Do lotions, tablets or light-based treatment help? 2013 Jan 13 [Updated 2019 Sep 26]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279210/
Jain, A.K.; Jain, A.; Garg, N.K.; Agarwal, A.; Jain, A.; Jain, S.A.; Tyagi, R.K.; Jain, R.K.; Agrawal, H.; Agrawal, G.P. Adapalene loaded solid lipid nanoparticles gel : An effective approach for acne treatment. Colloids. Surf. B. Biointerfaces., 2014, 121, 222- 229.
Kalabalik-Hoganson J, Frey KM, Ozdener-Poyraz AE, Slugocki M. Clascoterone: A novel topical androgen receptor inhibitor for the treatment of acne. Annals of Pharmacotherapy. 2021 Oct;55(10):1290-6.
Kaur, N.; Puri, R.; Jain, S.K. Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent. AAPS. Pharm. Sci. Tech., 2010, 11(2), 528-537.
Khoshbakht S, Asghari-Sana F, Fathi-Azarbayjani A, et al. Fabrication and characterization of tretinoin-loaded nanofiber for topical skin delivery. Biomater Res. 2020;24(1):8
Kim, J.; Kim, H.; Jeon, S.; Jo, J.; Kim, Y.; Kim, H. Synergistic Antibacterial Effects of Probiotic Lactic Acid Bacteria with Curcuma longa Rhizome Extract as Synbiotic against Cutibacterium acnes. Appl. Sci. 2020, 10, 8955
Kolli SS, Pecone D, Pona A, Cline A, Feldman SR. Topical retinoids in acne vulgaris: a systematic review. American Journal of Clinical Dermatology. 2019 Jun;20(3):345-65.
Kosmadaki M, Katsambas A. Topical treatments for acne. Clinics in dermatology. 2017 Mar 1;35(2):173-8.
Kraft J, Freiman A. Management of acne. CMAJ. 2011;183(7):E430-E435. doi:10.1503/cmaj.090374
Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clinical pharmacokinetics. 2003 Dec;42(14):1287-304.
Kumari, S.; Pandita, D.; Poonia, N.; Lather, V. Nanostuctured lipid carriers for topical delivery of an anti-acne drug: Characterization and ex-vivo evaluation. Pharm. Nanotechnol., 2015, 3(2), 122-133.
Layegh, P.; Mosallaei, N.; Bagheri, D.; Jaafari, M.R.; Golmohammadzadeh, S. The efficacy of isotretinoin-loaded solid lipid nanoparticles in comparison to Isotrex ® on acne treatment. Nanomed. J., 2014, 1(1), 38-47
Layton AM. A review on the treatment of acne vulgaris. International journal of clinical practice. 2006 Jan;60(1):64-72.
Leyden J, Stein-Gold L, Weiss J. Why topical retinoids are mainstay of therapy for acne. Dermatology and therapy. 2017 Sep;7(3):293-304.
Li J, Li J, Zhang L, Liu X, Cao Y, Wang P, Wang X. Comparison of red light and blue light therapies for mild‐to‐moderate acne vulgaris: A randomized controlled clinical study. Photodermatology, photoimmunology & photomedicine. 2022 Jan 3.
Miastkowska, M.; Sikora, E.; Ogonowski, J.; Zielin, M.; udzik. A. The kinetic study of isotretinoin release from nanoemulsion. Colloids. Surf. A., 2016, 510, 63-68.
Momen S, Al-Niaimi F. Acne vulgaris and light-based therapies. Journal of Cosmetic and Laser Therapy. 2015 May 4;17(3):122-8.
Najafi-Taher R, Amani A. Nanoemulsions: colloidal topical delivery systems for antiacne agents-A Mini-Review. Nanomedicine Research Journal. 2017 Feb 1;2(1):49-56.
Ochsendorf F. Minocycline in acne vulgaris. American journal of clinical dermatology. 2010 Oct;11(5):327-41.
Ogé LK, Broussard A, Marshall MD. Acne vulgaris: diagnosis and treatment. American family physician. 2019 Oct 15;100(8):475-84.
Otlewska A, Baran W, Batycka-Baran A. Adverse events related to topical drug treatments for acne vulgaris. Expert Opinion on Drug Safety. 2020 Apr 2;19(4):513-21.
Paiva-Santos AC, Mascarenhas-Melo F, Coimbra SC, Pawar KD, Peixoto D, Chá-Chá R, Araujo AR, Cabral C, Pinto S, Veiga F. Nanotechnology-based formulations toward the improved topical delivery of anti-acne active ingredients. Expert opinion on drug delivery. 2021 Oct 3;18(10):1435-54.
Patel R, Prabhu P. Nanocarriers as versatile delivery systems for effective management of acne. International Journal of Pharmaceutics. 2020 Apr 15;579:119140.
Patwekar, S.L.; Pedewad, S.R.; Gattani, S. Development and evaluation of nanostructured lipid carriers-based gel of isotretinoin. Part. Sci. Technol., 2017, 35, 1-12.
Pei S, Inamadar AC, Adya KA, Tsoukas MM. Light-based therapies in acne treatment. Indian dermatology online journal. 2015 May;6(3):145.
Piccolo D, Kostaki D, Dianzani C, Crisman G, Conforti C. Effective Intense Pulsed Light Protocol in the Treatment of Moderate to Severe Acne Vulgaris of the Chest and Back. J Clin Aesthet Dermatol. 2022;15(3):22-25.
Polonini H, Zander C, Radke J. CleodermTM Clarifying Cream: A Novel, Topical Vehicle Using Plant-Based Excipients and Actives Targeting Acne and Oily Skin. Journal of Cosmetics, Dermatological Sciences and Applications. 2021 Nov 5;11(4):381-99.
Purdy S, de Berker D. Acne vulgaris. BMJ clinical evidence. 2011;2011.
Qureshi, S.R.; Sahni, Y.P.; Singh, S.K.; Bhat, M.A.; Dar, A.A.; Quadri, S.A. Nanotechnology based drug delivery system. J. Pharm. Res. Opin., 2011, 1, 161-165.
Rahman, S.A; Abdelmalak, N.S.; Badawi, A.; Elbayoumy, T.; Sabry, N.; El Ramly, A. Tretinoin-loaded liposomal formulations: from lab to comparative clinical study in acne patients. Drug. Deliv., 2016, 23(4), 1184-1193.
Rigopoulos D, Larios G, Katsambas AD. The role of isotretinoin in acne therapy: why not as first-line therapy? Facts and controversies. Clin. Dermatol., 28: 24-30, 2010.
Sandoval LF, Hartel JK, Feldman SR. Current and future evidence-based acne treatment: a review. Expert opinion on pharmacotherapy. 2014 Feb 1;15(2):173-92.
Searle T, Ali FR, Al-Niaimi F. Zinc in dermatology. Journal of Dermatological Treatment. 2022 Apr 8:1-4.
Settelmeier S, Rassaf T, Hendgen-Cotta UB, Stoffels I. nitric oxide generating formulation as an innovative approach to topical skin care:An open-label pilot study. Cosmetics. 2021;8:16
Shah, K.A.; Date, A.A.; Joshi, M.D.; Patravale, V.B. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int. J. Pharm., 2007, 345(1-2), 163-171.
Shilakari, G.; Singh, D.; Asthana, A. Novel vesicular carriers for topical drug delivery and their application's. Int. J. Pharm. Sci. Rev. Res., 2013, 21(1), 77-86.
Simonart T. Newer approaches to the treatment of acne vulgaris. American journal of clinical dermatology. 2012 Dec;13(6):357-64.
Singh N, Singh M and Panwar S. An overview on Novel Drug Delivery Systems for Acne. Int. J. Res. Dev. Pharm. L. Sci. 2019; 8(4): 1- 12. doi: 10.13040/IJRDPL.2278-0238.8(4).1-12
Skalko, N.; Cajkovac, M.; Jalsenjak, I. Liposomes with clindamycin hydrochloride in the therapy of acne vulgaris. Int. J. Pharm., 1992, 85(1-3), 97-101.
Stuart B, Maund E, Wilcox C, Sridharan K, Sivaramakrishnan G, Regas C, Newell D, Soulsby I, Tang KF, Finlay AY, Bucher HC. Topical preparations for the treatment of mild‐to‐moderate acne vulgaris: systematic review and network meta‐analysis. British Journal of Dermatology. 2021 Sep;185(3):512-25.
Sunilendu, B.R.; Kothari, J.S.; Shafiq, S.; Pancholi, J.S.; Patel, J.D.; Ravindra, M. Pharmaceutical compositions of anti-acne agents. U.S Patent 2013/0280308 A1, October 24, 2013.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
Sutaria AH, Masood S, Schlessinger J. Acne Vulgaris. [Updated 2021 Aug 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459173/
Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. Int J Womens Dermatol. 2017;4(2):56-71. Published 2017 Dec 23. doi:10.1016/j.ijwd.2017.10.006
Tanghetti EA, Werschler WP, Lain T, Guenin E, Martin G, Pillai R. Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials. J Drugs Dermatol. 2020;19(1):70-77. doi:10.36849/JDD.2020.3977
Varun, T.; Sonia, A.; Bharat, P.; Patil, V. Niosomes and liposomes - vesicular approach towards transdermal drug delivery. Int. J. Pharm. Chem. Sci., 2012, 1(3), 981-993.
Vyas A, Kumar Sonker A, Gidwani B. Carrier-based drug delivery system for treatment of acne. ScientificWorldJournal. 2014;2014:276260. Published 2014 Feb 9. doi:10.1155/2014/276260
Vyas, J.; Vyas, P.; Raval, D.; Paghdar, P. Development of topical niosomal gel of benzoyl peroxide. Int. Sch. Res. Notices. Nanotechnol., 2011, 2011, 1-6.
Yang, D.; Pornpattananangkul, D.; Nakatsuji, T.; Chan, M.; Carson, D.; Huang, C.M.; Zhang, L. The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials, 2009, 30(30), 6035-6040.
Yeh L, Bonati LM, Silverberg NB. Topical retinoids for acne, 35, 2. 2016 Jun 1;35(2):50-6.
Zhanel G, Critchley I, Lin L-Y, Alvandi N. Microbiological profile of sarecycline, a novel targeted spectrum tetracycline for the treatment of acne vulgaris. Antimicrob. Agents Chemother. 63(1), e01297–e01218 (2019).
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
